- EDC systems, designed to collect and manage clinical trial data electronically, are becoming indispensable tools in modern clinical research due to their real-time data access, improved data accuracy, and compatibility with remote and decentralized trial models in both academic and commercial settings
- The growing demand for EDC systems is primarily driven by increasing clinical trial activities, the need for streamlined regulatory compliance, and the industry-wide shift toward paperless and patient-centric trial operations
- North America dominated the electronic data capture (EDC) systems market with the largest revenue share of 41.8% in 2024, supported by robust healthcare infrastructure, high R&D investments, and early adoption of digital technologies, with the U.S. leading the trend through major pharmaceutical and biotech firms embracing cloud-based and AI-integrated platforms
- Asia-Pacific is expected to be the fastest growing region in the electronic data capture (EDC) systems market during the forecast period due to expanding clinical trial operations, regulatory modernization, and the growing presence of contract research organizations (CROs)
- Web-hosted segment dominated the electronic data capture (EDC) systems market with a market share of 52.9% in 2024, driven by its ease of deployment, cost-efficiency, and widespread accessibility for multi-site clinical trials
